Pan-cancer immunogenomic analyses reveal sex disparity in the efficacy of cancer immunotherapy

Eur J Cancer. 2020 Feb:126:136-138. doi: 10.1016/j.ejca.2019.12.008. Epub 2020 Jan 9.

¹ Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China. Electronic address: owangpengfei2008@126.com.
² Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Research Center for Genitourinary Oncology, Beijing, China. Electronic address: songhf@bjmu.edu.cn.
³ Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Research Center for Genitourinary Oncology, Beijing, China. Electronic address: zhangqianbjmu@126.com.
⁴ Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China. Electronic address: yancx65828@sina.com.

No abstract available

Keywords: Cancer; Immune checkpoint inhibitors; Immunotherapy; Sex-based discrepancy.

Publication types